Intravenous products: NP Medical reports “NP Medical (www.npmedical.com) has released a new, patented, needle-free access device intended to help clinicians reduce the risk of catheter-related bloodstream infections (CRBSI) and connector reflux-induced catheter occlusions during infusion therapy. Called nPulse™, the new device has been designed to complement best clinical practices as designated by the Infusion Nurses Society(INS) and the Centers for Disease Control (CDC).
Luis J. Maseda, General Manger of NP Medical, announced that the new nPulse device has been cleared by the U. S. Food and Drug Administration for marketing in the United States. “This device is the outgrowth of the collaborative commercialization of innovative products with NP Medical’s OEM customers for more than 30 years,” said Mr. Maseda. “nPulse™ represents the pinnacle of evolution of minimal fluid displacement needle-free connectors,” he added. The nPulse™ product combines a number of clinically desirable attributes, including non-refluxing fluid displacement, high pressure rating to 325 psi, a flat swabable surface and a clear housing for direct visualization of the fluid path which facilitates clinical decision-making.”